With many asset owners historically reticent, and some unable, to invest in the renewable energy market, has 2021 proved a turning point for institutional investor appetite in this crucial asset class?
Net-zero emission pledges are under growing scrutiny from investors amid worries over the gaming of carbon reporting. Governments are facing rising pressure to ensure accountability for such commitments.
The US drugs giant will use proceeds from its second sustainability bond issue to tackle the pandemic, including in emerging markets. ESG head Chris Gray seeks to dispel scepticism by explaining the deal's rationale, while treasurer Brian McMahon discusses the $1bn bond’s pricing.
Passive investing has been posed as a threat to the planet – but how far does the data support these claims?
The idea of incorporating gross national happiness into mainstream economic thought has long been a subject reserved for debating societies and 'lefty' thinkers. As politicians are cornered into taking immediate action on climate change, capitalism is in for a big surprise.
America's solar industry has faced challenges getting financing, but investor and public sentiment is improving and government support is growing. A $400m debt issue last month was another positive sign.
The A$150bn pension fund is using its financial heft to address modern slavery and has developed a risk-assessment tool to support its reporting requirements. But while some asset managers have shown overwhelming support, others are still burying their heads in the sand.
One-fifth – and counting – of the world’s largest companies have committed to achieve net-zero carbon emissions, largely by 2050. But there is no legal or regulatory recourse if they don't, and seemingly little appetite for that to change.
Medical device maker Nipro has become a rare Japanese issuer of a sustainability-linked loan, and the first from the healthcare sector. Disclosed details are limited, but it aims to use the proceeds to help address Covid-19 issues and generally improve public health both domestically and overseas.
The year to date has seen record-breaking support for shareholder resolutions, with asset managers such as BlackRock and Vanguard stepping up their stewardship. However, a lack of data on the real-world impact means the jury is still out on their efficacy.